124 related articles for article (PubMed ID: 31225497)
21. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
22. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
[TBL] [Abstract][Full Text] [Related]
23. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
24. A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7.
Cui XY; Skretting G; Tinholt M; Stavik B; Dahm AEA; Sahlberg KK; Kanse S; Iversen N; Sandset PM
Thromb Res; 2017 Sep; 157():111-116. PubMed ID: 28734156
[TBL] [Abstract][Full Text] [Related]
25. The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer.
Cheng FY; Chan CH; Wang BJ; Yeh YL; Wang YJ; Chiu HW
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546453
[TBL] [Abstract][Full Text] [Related]
26. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
Li YM; Zhou BP; Deng J; Pan Y; Hay N; Hung MC
Cancer Res; 2005 Apr; 65(8):3257-63. PubMed ID: 15833858
[TBL] [Abstract][Full Text] [Related]
27. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
28. Lactobacilli Modulate Hypoxia-Inducible Factor (HIF)-1 Regulatory Pathway in Triple Negative Breast Cancer Cell Line.
Esfandiary A; Taherian-Esfahani Z; Abedin-Do A; Mirfakhraie R; Shirzad M; Ghafouri-Fard S; Motevaseli E
Cell J; 2016; 18(2):237-244. PubMed ID: 27540529
[TBL] [Abstract][Full Text] [Related]
29. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
32. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.
Lee JW; Bae SH; Jeong JW; Kim SH; Kim KW
Exp Mol Med; 2004 Feb; 36(1):1-12. PubMed ID: 15031665
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
[TBL] [Abstract][Full Text] [Related]
35. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
36. Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.
Kim KK; Abelman S; Yano N; Ribeiro JR; Singh RK; Tipping M; Moore RG
Sci Rep; 2015 Oct; 5():14296. PubMed ID: 26469226
[TBL] [Abstract][Full Text] [Related]
37. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
38. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
Floyd ZE; Kilroy G; Wu X; Gimble JM
J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
[TBL] [Abstract][Full Text] [Related]
39. Acute Methylmercury Exposure and the Hypoxia-Inducible
Chang J; Yang B; Zhou Y; Yin C; Liu T; Qian H; Xing G; Wang S; Li F; Zhang Y; Chen D; Aschner M; Lu R
Environ Health Perspect; 2019 Dec; 127(12):127006. PubMed ID: 31850806
[TBL] [Abstract][Full Text] [Related]
40. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
Chan DA; Sutphin PD; Yen SE; Giaccia AJ
Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
